{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:05:57Z","timestamp":1757700357646,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02323-4","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T18:04:15Z","timestamp":1652292255000},"page":"3221-3228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of knowledge, attitude, and behaviour of ophthalmologists about adenoviral conjunctivitis transmission and treatment"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6989-4378","authenticated-orcid":false,"given":"Gozde","family":"Sahin Vural","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Barut Selver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melis","family":"Palamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"2323_CR1","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/archopht.1982.01030040253009","volume":"100","author":"S Stenson","year":"1982","unstructured":"Stenson S, Newman R, Fedukowicz H (1982) Laboratory studies in acute conjunctivitis. Arch Ophthalmol 100:1275\u20131277. https:\/\/doi.org\/10.1001\/archopht.1982.01030040253009","journal-title":"Arch Ophthalmol"},{"key":"2323_CR2","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1038\/eye.1988.135","volume":"2","author":"RM Woodland","year":"1988","unstructured":"Woodland RM (1988) Laboratory diagnosis of chlamydial and viral ocular infections. Eye 2:S70\u2013S80. https:\/\/doi.org\/10.1038\/eye.1988.135","journal-title":"Eye"},{"key":"2323_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S0161-6420(89)32749-7","volume":"96","author":"CP Fitch","year":"1989","unstructured":"Fitch CP, Rapoza PA, Owens S et al (1989) Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology 96:1215\u20131220. https:\/\/doi.org\/10.1016\/S0161-6420(89)32749-7","journal-title":"Ophthalmology"},{"key":"2323_CR4","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ajo.2006.07.041","volume":"142","author":"XH Jin","year":"2006","unstructured":"Jin XH, Ishiko H, Thanh Ha N et al (2006) Molecular epidemiology of adenoviral conjunctivitis in Hanoi, Vietnam. Am J Ophthalmol 142:1064\u20131066. https:\/\/doi.org\/10.1016\/j.ajo.2006.07.041","journal-title":"Am J Ophthalmol"},{"key":"2323_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.ico.0000170693.13326.fb","volume":"25","author":"AL Butt","year":"2006","unstructured":"Butt AL, Chodosh J (2006) Adenoviral keratoconjunctivitis in a tertiary care eye clinic. Cornea 25:199\u2013202. https:\/\/doi.org\/10.1097\/01.ico.0000170693.13326.fb","journal-title":"Cornea"},{"key":"2323_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/rmv.589","volume":"18","author":"L Lenaerts","year":"2008","unstructured":"Lenaerts L, De Clercq E, Naesens L (2008) Clinical features and treatment of adenovirus infections. Rev Med Virol 18:357\u2013374","journal-title":"Rev Med Virol"},{"key":"2323_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.optm.2006.11.012","volume":"78","author":"RP Sambursky","year":"2007","unstructured":"Sambursky RP, Fram N, Cohen EJ (2007) The prevalence of adenoviral conjunctivitis at the Wills Eye Hospital Emergency Room. Optometry 78:236\u2013239. https:\/\/doi.org\/10.1016\/j.optm.2006.11.012","journal-title":"Optometry"},{"key":"2323_CR8","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1185\/03007990903038269","volume":"25","author":"TP O\u2019Brien","year":"2009","unstructured":"O\u2019Brien TP, Jeng BH, McDonald M, Raizman MB (2009) Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin 25:1953\u20131961. https:\/\/doi.org\/10.1185\/03007990903038269","journal-title":"Curr Med Res Opin"},{"key":"2323_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/ICU.0b013e3283477cb5","volume":"22","author":"HE Kaufman","year":"2011","unstructured":"Kaufman HE (2011) Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol 22:290\u2013293. https:\/\/doi.org\/10.1097\/ICU.0b013e3283477cb5","journal-title":"Curr Opin Ophthalmol"},{"key":"2323_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-0420.2007.01006.x","volume":"86","author":"G H\u00f8vding","year":"2008","unstructured":"H\u00f8vding G (2008) Acute bacterial conjunctivitis. Acta Ophthalmol 86:5\u201317","journal-title":"Acta Ophthalmol"},{"key":"2323_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0002-9394(70)92285-3","volume":"69","author":"CR Dawson","year":"1970","unstructured":"Dawson CR, Hanna L, Wood TR, Despain R (1970) Adenovirus type 8 keratoconjunctivitis in the United States. III. Epidemiologic, clinical, and microbiologic features. Am J Ophthalmol 69:473\u2013480. https:\/\/doi.org\/10.1016\/0002-9394(70)92285-3","journal-title":"Am J Ophthalmol"},{"key":"2323_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2807\/esm.11.07.00637-en","volume":"11","author":"A Schrauder","year":"2006","unstructured":"Schrauder A, Altmann D, Laude G et al (2006) Epidemic conjunctivitis in Germany, 2004. Eurosurveillance 11:7\u20138. https:\/\/doi.org\/10.2807\/esm.11.07.00637-en","journal-title":"Eurosurveillance"},{"key":"2323_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/MAJ.0b013e3181637417","volume":"336","author":"BL Udeh","year":"2008","unstructured":"Udeh BL, Schneider JE, Ohsfeldt RL (2008) Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. Am J Med Sci 336:254\u2013264. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181637417","journal-title":"Am J Med Sci"},{"key":"2323_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/infdis\/147.2.191","volume":"147","author":"RA Keenlyside","year":"1983","unstructured":"Keenlyside RA, Hierholzer JC, D\u2019Angelo LJ (1983) Keratoconjunctivitis associated with adenovirus type 37: an extended outbreak in an ophthalmologist\u2019s office. J Infect Dis 147:191\u2013198. https:\/\/doi.org\/10.1093\/infdis\/147.2.191","journal-title":"J Infect Dis"},{"key":"2323_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/bjo.2007.130112","volume":"93","author":"JKG Dart","year":"2009","unstructured":"Dart JKG, El-Amir AN, Maddison T et al (2009) Identification and control of nosocomial adenovirus keratoconjunctivitis in an ophthalmic department. Br J Ophthalmol 93:18\u201320. https:\/\/doi.org\/10.1136\/bjo.2007.130112","journal-title":"Br J Ophthalmol"},{"key":"2323_CR16","unstructured":"Kolluru V, Couser NL (2020) Epidemic Keratoconjunctivitis\u2014EyeWiki. In: Am. Acad. Ophthalmol. https:\/\/eyewiki.aao.org\/Epidemic_Keratoconjunctivitis#References. Accessed 21 Jan 2022"},{"key":"2323_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2020-000509","volume":"5","author":"M Edington","year":"2020","unstructured":"Edington M, Ramaesh K, Lockington D (2020) Virucidal benefits of povidone-iodine use on the ocular surface: a review. BMJ Open Ophthalmol 5:e000509. https:\/\/doi.org\/10.1136\/bmjophth-2020-000509","journal-title":"BMJ Open Ophthalmol"},{"key":"2323_CR18","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jtos.2019.08.005","volume":"17","author":"E Shorter","year":"2019","unstructured":"Shorter E, Whiteside M, Harthan J et al (2019) Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: the reducing adenoviral patient infected days (RAPID) study. Ocul Surf 17:828\u2013832. https:\/\/doi.org\/10.1016\/j.jtos.2019.08.005","journal-title":"Ocul Surf"},{"key":"2323_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/jop.2011.0082","volume":"28","author":"A Trinavarat","year":"2012","unstructured":"Trinavarat A, Atchaneeyasakul LO (2012) Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study. J Ocul Pharmacol Ther 28:53\u201358. https:\/\/doi.org\/10.1089\/jop.2011.0082","journal-title":"J Ocul Pharmacol Ther"},{"key":"2323_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/s-2006-926633","volume":"223","author":"N Monnerat","year":"2006","unstructured":"Monnerat N, Bossart W, Thiel MA (2006) Povidoniod zur behandlung von adenoviruskonjunktivitis: eine in-vitro-studie. Klin Monatsbl Augenheilkd 223:349\u2013352","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"2323_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/00003226-199305000-00006","volume":"12","author":"JB Ward","year":"1993","unstructured":"Ward JB, Siojo LG, Waller SG (1993) A prospective, masked clinical trial of trifluridine, dexamethasone, and artificial tears in the treatment of epidemic keratoconjunctivitis. Cornea 12:216\u2013221. https:\/\/doi.org\/10.1097\/00003226-199305000-00006","journal-title":"Cornea"},{"key":"2323_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/jac\/dki057","volume":"55","author":"PR Kinchington","year":"2005","unstructured":"Kinchington PR, Romanowski EG, Gordon YJ (2005) Prospects for adenovirus antivirals. J Antimicrob Chemother 55:424\u2013429","journal-title":"J Antimicrob Chemother"},{"key":"2323_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00003226-200204000-00010","volume":"21","author":"EG Romanowski","year":"2002","unstructured":"Romanowski EG, Yates KA, Gordon YJ (2002) Topical corticosteroids of limited potency promote adenovirus replication in the Ad5\/NZW rabbit ocular model. Cornea 21:289\u2013291. https:\/\/doi.org\/10.1097\/00003226-200204000-00010","journal-title":"Cornea"},{"key":"2323_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1001\/archopht.1996.01100130573014","volume":"114","author":"EG Romanowski","year":"1996","unstructured":"Romanowski EG, Roba LA, Wiley L et al (1996) The effects of corticosteroids on adenoviral replication. Arch Ophthalmol 114:581\u2013585. https:\/\/doi.org\/10.1001\/archopht.1996.01100130573014","journal-title":"Arch Ophthalmol"},{"key":"2323_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/00003226-200108000-00020","volume":"20","author":"EG Romanowski","year":"2001","unstructured":"Romanowski EG, Yates KA, Gordon YJ (2001) Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit. Cornea 20:657\u2013660. https:\/\/doi.org\/10.1097\/00003226-200108000-00020","journal-title":"Cornea"},{"key":"2323_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1046\/j.1442-9071.2003.00708.x","volume":"31","author":"PJ McAllum","year":"2003","unstructured":"McAllum PJ, McGhee CNJ (2003) Prescribing trends in infectious keratitis: a survey of New Zealand ophthalmologists. Clin Exp Ophthalmol 31:496\u2013504. https:\/\/doi.org\/10.1046\/j.1442-9071.2003.00708.x","journal-title":"Clin Exp Ophthalmol"},{"key":"2323_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/archopht.1970.00990040038010","volume":"84","author":"PR Laibson","year":"1970","unstructured":"Laibson PR, Dhiri S, Oconer J, Ortolan G (1970) Corneal infiltrates in epidemic keratoconjunctivitis: response to double-blind corticosteroid therapy. Arch Ophthalmol 84:36\u201340. https:\/\/doi.org\/10.1001\/archopht.1970.00990040038010","journal-title":"Arch Ophthalmol"},{"key":"2323_CR28","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0161-6420(00)00177-9","volume":"107","author":"Y Shiuey","year":"2000","unstructured":"Shiuey Y, Ambati BK, Adamis AP (2000) A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis. Ophthalmology 107:1512\u20131517. https:\/\/doi.org\/10.1016\/S0161-6420(00)00177-9","journal-title":"Ophthalmology"},{"key":"2323_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/003591575805101105","volume":"51","author":"BR Jones","year":"1958","unstructured":"Jones BR (1958) The clinical features of viral keratitis and a concept of their pathogenesis. Proc R Soc Med 51:917\u2013924. https:\/\/doi.org\/10.1177\/003591575805101105","journal-title":"Proc R Soc Med"},{"key":"2323_CR30","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/ICO.0b013e31820cd607","volume":"30","author":"BH Jeng","year":"2011","unstructured":"Jeng BH, Holsclaw DS (2011) Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis. Cornea 30:958\u2013961. https:\/\/doi.org\/10.1097\/ICO.0b013e31820cd607","journal-title":"Cornea"},{"key":"2323_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/ICO.0b013e3181c33034","volume":"29","author":"E Levinger","year":"2010","unstructured":"Levinger E, Slomovic A, Sansanayudh W et al (2010) Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Cornea 29:638\u2013640. https:\/\/doi.org\/10.1097\/ICO.0b013e3181c33034","journal-title":"Cornea"},{"key":"2323_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/01.ico.0000127481.23714.b6","volume":"24","author":"EG Romanowski","year":"2005","unstructured":"Romanowski EG, Pless P, Yates KA, Gordon YJ (2005) Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models. Cornea 24:86\u201391. https:\/\/doi.org\/10.1097\/01.ico.0000127481.23714.b6","journal-title":"Cornea"},{"key":"2323_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.oftal.2012.07.007","volume":"88","author":"JJ Gonz\u00e1lez-L\u00f3pez","year":"2013","unstructured":"Gonz\u00e1lez-L\u00f3pez JJ, Morcillo-Laiz R, Mu\u00f1oz-Negrete FJ (2013) Queratoconjuntivitis adenov\u00edricas: actualizaci\u00f3n. Arch Soc Esp Oftalmol 88:108\u2013115","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2323_CR34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/oxfordjournals.epirev.a036304","volume":"9","author":"E Ford","year":"1987","unstructured":"Ford E, Nelson KE, Warren D (1987) Epidemiology of epidemic Kerato conjunctivitis. Epidemiol Rev 9:244\u2013261. https:\/\/doi.org\/10.1093\/oxfordjournals.epirev.a036304","journal-title":"Epidemiol Rev"},{"key":"2323_CR35","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1073\/pnas.57.5.1302","volume":"57","author":"M Green","year":"1967","unstructured":"Green M, Pi\u00f1a M, Kimes R et al (1967) Adenovirus DNA. I. Molecular weight and conformation. Proc Natl Acad Sci USA 57:1302\u20131309. https:\/\/doi.org\/10.1073\/pnas.57.5.1302","journal-title":"Proc Natl Acad Sci USA"},{"key":"2323_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/sj.eye.6700330","volume":"17","author":"D Cheung","year":"2003","unstructured":"Cheung D, Bremner J, Chan JTK (2003) Epidemic keratoconjunctivitis\u2014do outbreaks have to be epidemic? Eye 17:356\u2013363. https:\/\/doi.org\/10.1038\/sj.eye.6700330","journal-title":"Eye"},{"key":"2323_CR37","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0161-6420(93)31389-8","volume":"100","author":"YJ Gordon","year":"1993","unstructured":"Gordon YJ, Gordon RY, Romanowski E, Araullo-Cruz TP (1993) Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology 100:1835\u20131840. https:\/\/doi.org\/10.1016\/S0161-6420(93)31389-8","journal-title":"Ophthalmology"},{"key":"2323_CR38","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0161-6420(90)32389-8","volume":"97","author":"RC Nauheim","year":"1990","unstructured":"Nauheim RC, Romanowski EG, Araullo-Cruz T et al (1990) Prolonged recoverability of desiccated adenovirus type 19 from various surfaces. Ophthalmology 97:1450\u20131453. https:\/\/doi.org\/10.1016\/S0161-6420(90)32389-8","journal-title":"Ophthalmology"},{"key":"2323_CR39","first-page":"539","volume":"94","author":"JD Gottsch","year":"1996","unstructured":"Gottsch JD (1996) Surveillance and control of epidemic keratoconjunctivitis. Trans Am Ophthalmol Soc 94:539\u2013587","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2323_CR40","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1128\/AAC.50.4.1419-1424.2006","volume":"50","author":"WA Rutala","year":"2006","unstructured":"Rutala WA, Peacock JE, Gergen MF et al (2006) Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities. Antimicrob Agents Chemother 50:1419\u20131424. https:\/\/doi.org\/10.1128\/AAC.50.4.1419-1424.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2323_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5688\/AJ720243","volume":"72","author":"JE Fincham","year":"2008","unstructured":"Fincham JE (2008) Response rates and responsiveness for surveys, standards, and the journal. Am J Pharm Educ 72:43. https:\/\/doi.org\/10.5688\/AJ720243","journal-title":"Am J Pharm Educ"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02323-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T15:29:56Z","timestamp":1664033396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02323-4"}},"subtitle":["An online survey for Turkish ophthalmologists"],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2323"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02323-4","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of HELSINKI and its later amendments or comparable ethical standards. The study was approved by Ege University, Faculty of Medicine, Surgical and Pharmaceutical Research Ethics Board (IRB: 2019\/0512).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for participation and publication was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}